Dr. Morgane Daix: what changed
Dr. Morgane Daix
Largest movements
- Cash -€70,133
down €70,133 (-61.5%), from €114,028 to €43,895
mainly Other debts (-€85,805) and Contributions, distributions and other (-€48,600)
- Current investments -€24,999
down €24,999 (-100%), from €24,999 to €0
- Receivables within one year -€9,381
down €9,381 (-43.2%), from €21,705 to €12,324
- Deferred charges and accrued income -€5,753
down €5,753 (-56.7%), from €10,144 to €4,391
- Other debts -€85,805
down €85,805 (-63.6%), from €135,000 to €49,195
- Tax, wage and social debts -€18,229
down €18,229 (-79.2%), from €23,029 to €4,800
- Profit (loss) carried forward -€7,693
down €7,693 (-89.6%), from €8,584 to €892
- Gross operating margin -€29,915
down €29,915 (-38.6%), from €77,558 to €47,643
- Taxes -€10,523
down €10,523 (-50.0%), from €21,033 to €10,510
- Financial income +€4,408
up €4,408 (+324%), from €1,359 to €5,767
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €170,876 | €60,670 | -€110,206 | -64.5% |
| Fixed assets | 21/28 | - | €60 | +€60 | |
| Financial fixed assets | 28 | - | €60 | +€60 | |
| Current assets | 29/58 | €170,876 | €60,610 | -€110,266 | -64.5% |
| Amounts receivable within one year | 40/41 | €21,705 | €12,324 | -€9,381 | -43.2% |
| Other amounts receivable | 41 | €21,705 | €12,324 | -€9,381 | -43.2% |
| Current investments | 50/53 | €24,999 | €0 | -€24,999 | -100% |
| Cash at bank and in hand | 54/58 | €114,028 | €43,895 | -€70,133 | -61.5% |
| Deferred charges and accrued income | 490/1 | €10,144 | €4,391 | -€5,753 | -56.7% |
| Total equity and liabilities | 10/49 | €170,876 | €60,670 | -€110,206 | -64.5% |
| Equity | 10/15 | €11,584 | €3,892 | -€7,693 | -66.4% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €8,584 | €892 | -€7,693 | -89.6% |
| Amounts payable | 17/49 | €159,292 | €56,779 | -€102,513 | -64.4% |
| Amounts payable within one year | 42/48 | €158,681 | €56,148 | -€102,533 | -64.6% |
| Trade debts | 44 | €652 | €2,153 | +€1,502 | +230% |
| Suppliers | 440/4 | €652 | €2,153 | +€1,502 | +230% |
| Taxes, remuneration and social security | 45 | €23,029 | €4,800 | -€18,229 | -79.2% |
| Taxes | 450/3 | €23,029 | €4,800 | -€18,229 | -79.2% |
| Other amounts payable | 47/48 | €135,000 | €49,195 | -€85,805 | -63.6% |
| Accrued charges and deferred income | 492/3 | €611 | €631 | +€20 | +3.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €340 | €0 | -€340 | -100% |
| Other operating charges | 640/8 | €728 | €994 | +€266 | +36.6% |
| Gross operating margin | 9900 | €77,558 | €47,643 | -€29,915 | -38.6% |
| Operating profit (loss) | 9901 | €76,491 | €46,649 | -€29,842 | -39.0% |
| Financial income | 75/76B | €1,359 | €5,767 | +€4,408 | +324% |
| Recurring financial income | 75 | €1,359 | €5,767 | +€4,408 | +324% |
| Financial charges | 65/66B | €619 | €999 | +€380 | +61.4% |
| Recurring financial charges | 65 | €619 | €999 | +€380 | +61.4% |
| Profit (loss) for the period before taxes | 9903 | €77,231 | €51,418 | -€25,814 | -33.4% |
| Income taxes | 67/77 | €21,033 | €10,510 | -€10,523 | -50.0% |
| Profit (loss) for the period | 9904 | €56,198 | €40,907 | -€15,291 | -27.2% |
| Profit (loss) for the period to be appropriated | 9905 | €56,198 | €40,907 | -€15,291 | -27.2% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.